Multidrug-resistant pathogens in patients with pneumonia coming from the community

Current Opinion in Pulmonary Medicine

Volumn 22, Issue 3, 2016, Pages 219-226

  Sibila, Oriol ^a   Rodrigo Troyano, Ana ^a   Shindo, Yuichiro ^b   Aliberti, Stefano ^c   Restrepo, Marcos I ^d  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

community acquired pneumonia; healthcare associated pneumonia; methicillin resistant Staphylococcus aureus; Pseudomonas; risk scores

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIMICROBIAL THERAPY; CHRONIC KIDNEY FAILURE; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; HEMODIALYSIS; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTICENTER STUDY (TOPIC); MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; REVIEW; RISK FACTOR; PNEUMONIA;

DRUG RESISTANCE, MULTIPLE; HUMANS; PNEUMONIA; RISK FACTORS;

EID: 84962680692     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000263     Document Type: Review

References (45)

1. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
2. Micek ST, Kollef KE, Reichley RM, et al. Healthcare-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51:3568-3573.
3. Shindo Y, Sato S, Maruyama E, et al. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009; 135:633-640.
4. Depuydt P, Putman B, Benoit D, et al. Nursing home residence is the main risk factor for increased mortality in healthcare-associated pneumonia. J Hosp Infect 2011; 77:138-142.
5. Garcia-Vidal C, Viasus D, Roset A, et al. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hos-pitalization. Clin Microbiol Infect 2011; 17:1659-1665.
6. Grenier C, Pepin J, Nault V, et al. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. J Antimicrob Chemother 2011; 66:1617-1624.
7. Jeon EJ, Cho SG, Shin JW, et al. The difference in clinical presentations between healthcare-associated and community-acquired pneumonia in university-affiliated hospital in Korea. Yonsei Med J 2011; 52:282-287.
8. Jung JY, Park MS, Kim YS, et al. Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital. BMC Infect Dis 2011; 11:61.
9. Kollef MH, Zilberberg MD, Shorr AF, et al. Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect 2011; 62:130-135.
10. Seki M, Hashiguchi K, Tanaka A, et al. Characteristics and disease severity of healthcare-associated pneumonia among patients in a hospital in Kitakyushu, Japan. J Infect Chemother 2011; 17:363-369.
11. Umeki K, Tokimatsu I, Yasuda C, et al. Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia. Respirology 2011; 16:856-861.
12. Carrabba M, Zarantonello M, Bonara P, et al. Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression. Eur Respir J 2012; 40:1201-1210.
13. Giannella M, Pinilla B, Capdevila JA, et al. Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Mi-crobiol Infect 2012; 18:786-794.
14. Hoo LJ, Hyung KY. Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals. Braz J Infect Dis 2012; 16:321-328.
15. Ishida T, Tachibana H, Ito A, et al. Clinical characteristics of nursing and healthcare-associated pneumonia: a Japanese variant of healthcare-associated pneumonia. Intern Med 2012; 51:2537-2544.
16. Miyashita N, Kawai Y, Akaike H, et al. Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital. Intern Med 2012; 51:585-594.
17. Simonetti A, Viasus D, Garcia-Vidal C, et al. Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia. Clin Microbiol Infect 2012; 18:1149-1155.
18. Sugisaki M, Enomoto T, Shibuya Y, et al. Clinical characteristics of healthcare-associated pneumonia in a public hospital in a metropolitan area of Japan. J Infect Chemother 2012; 18:352-360.
19. Fukuyama H, Yamashiro S, Tamaki H, Kishaba T. A prospective comparison of nursing-and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP). J Infect Chemother 2013; 19:719-726.
20. Jeong BH, Koh WJ, Yoo H, et al. Performances of prognostic scoring systems in patients with healthcare-associated pneumonia. Clin Infect Dis 2013; 56:625-632.
21. Oshitani Y, Nagai H, Matsui H, Aoshima M. Reevaluation of the Japanese guideline for healthcare-associated pneumonia in a medium-sized community hospital in Japan. J Infect Chemother 2013; 19:579-587.
22. Wunderink RG. Community-acquired pneumonia versus healthcare-associated pneumonia. The returning pendulum. Am J Respir Crit Care Med 2013; 188:896-898.
23. Ewig S. HCAP not busy being born is busy dying. Am J Respir Crit Care Med 2014; 189:365-366.
24. Restrepo MI, Aliberti S. Healthcare-associated pneumonia: where do we go next? Clin Infect Dis 2014; 58:340-341.
25. Chalmers JD, Rother C, Salih W, Ewig S. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis 2014; 58:330-339.
26. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for healthcare-associated pneumonia. Arch Intern Med 2008; 168:2205-2210.
27. Chalmers JD, Taylor JK, Singanayagam A, et al. Epidemiology, antibiotic therapy, and clinical outcomes in healthcare-associated pneumonia: a UK cohort study. Clin Infect Dis 2011; 53:107-113.
28. Aliberti S, Di PM, Zanaboni AM, et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 2012; 54:470-478.
29. Park SC, Kang YA, Park BH, et al. Poor prediction of potentially drug-resistant pathogens using current criteria of healthcare-associated pneumonia. Respir Med 2012; 106:1311-1319.
30. Park SC, Kim EY, Kang YA, et al. Validation of a scoring tool to predict drug-resistant pathogens in hospitalised pneumonia patients. Int J Tuberc Lung Dis 2013; 17:704-709.
31. Shindo Y, Ito R, Kobayashi D, et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med 2013; 188:985-995.
32. Gross AE, Van Schooneveld TC, Olsen KM, et al. Epidemiology and predictors of multidrug-resistant community-acquired and healthcare-associated pneumonia. Antimicrob Agents Chemother 2014; 58:5262-5268.
33. Ma HM, Ip M, Woo J, Hui DS. Development and validation of a clinical risk score for predicting drug-resistant bacterial pneumonia in older Chinese patients. Respirology 2014; 19:549-555.
34. Prina E, Ranzani OT, Polverino E, et al. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia. Ann Am Thorac Soc 2015; 12:153-160.
35. Torres A, Cillóniz C, Ferrer M, et al. Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis. Eur Respir J 2015; 45:1353-1363.
36. Maruyama T, Fujisawa T, Okuno M, et al. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clin Infect Dis 2013; 57:1373-1383.
37. Shorr AF, Zilberberg MD, Reichley R, et al. Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 2012; 54:193-198.
38. Shorr AF, Myers DE, Huang DB, et al. A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis 2013; 13:268.
39. Arancibia F, Bauer TT, Ewig S, et al. Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med 2002; 162:1849-1858.
40. von Baum H, Welte T, Marre R, et al. Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors. Eur Respir J 2010; 35:598-605.
41. Kang CI, Song JH, Oh WS, et al. Clinical outcomes and risk factors of community-acquired pneumonia caused by gram-negative bacilli. Eur J Clin Microbiol Infect Dis 2008; 27:657-661.
42. Falguera M, Carratala J, Ruiz-Gonzalez A, et al. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli. Respirology 2009; 14:105-111.
43. Sibila O, Laserna E, Maselli DJ, et al. Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia. Respirology 2015; 20:660-666.
44. Davis JS, McMillan M, Swaminathan A, et al. A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols. Chest 2014; 146:1038-1045.
45. Aliberti S, Cilloniz C, Chalmers JD, et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a Eur opean perspective. Thorax 2013; 68:997-999.